Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2013

01.05.2013 | Epidemiology

Alcohol intake over the life course and breast cancer survival in Western New York exposures and breast cancer (WEB) study: quantity and intensity of intake

verfasst von: Anne M. Weaver, Susan E. McCann, Jing Nie, Stephen B. Edge, Thomas H. Nochajski, Marcia Russell, Maurizio Trevisan, Jo L. Freudenheim

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Alcohol intake is a risk factor for breast cancer, but the association between alcohol and mortality among breast cancer survivors is poorly understood. We examined the association between alcohol intake from all sources, assessed by cognitive lifetime drinking history, and all-cause and breast cancer mortality among women with breast cancer (N = 1,097) who participated in a population-based case–control study. Vital status was ascertained through 2006 using the National Death Index. Using Cox proportional hazards models, we computed hazard ratios for all-cause and breast cancer mortality in association with alcohol intake. We examined lifetime volume and intensity (drinks per drinking day) of alcohol consumption as well as drinking status during various life periods. Analyses were stratified by menopausal status. After adjustment for total intake, postmenopausal women with consumption of four or more drinks per drinking day over their lifetimes were nearly three times more likely to die from any cause compared to abstainers (HR 2.94, 95 % CI 1.31, 6.62). There was a similar but non-significant association with breast cancer mortality (HR 2.68, 95 % CI 0.94, 7.67). Postmenopausal women who drank one drink or fewer per drinking day between menarche and first birth had a significantly decreased hazard of all-cause (HR 0.54, 95 % CI 0.31, 0.95) and breast cancer mortality (HR 0.27, 95 % CI 0.09, 0.77). Premenopausal breast cancer survival was not associated with drinking intensity. We observed no associations between drinking status or total volume of alcohol intake and breast cancer or all-cause mortality. High-intensity alcohol consumption may be associated with decreased survival in postmenopausal women with breast cancer. Low-intensity alcohol consumption between menarche and first birth may be inversely associated with all-cause and breast cancer mortality; this period may be critical for development of and survival from breast cancer. Intensity of alcohol intake may be a more important factor than absolute volume of intake on survival in women with breast cancer.
Literatur
1.
Zurück zum Zitat American Cancer Society (2012) Cancer facts and figures 2012. Atlanta, GA American Cancer Society (2012) Cancer facts and figures 2012. Atlanta, GA
2.
Zurück zum Zitat Singletary KW, Gapstur SM (2001) Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. J Am Med Assoc 286(17):2143–2151CrossRef Singletary KW, Gapstur SM (2001) Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. J Am Med Assoc 286(17):2143–2151CrossRef
3.
Zurück zum Zitat Tjonneland A, Christensen J, Olsen A, Stripp C, Thomsen BL, Overvad K, Peeters PHM, van Gils CH, Bueno-de-Mesquita HB, Ocke MC, Thiebaut A, Fournier A, Clavel-Chapelon F, Berrino F, Palli D, Tumino R, Panico S, Vineis P, Agudo A, Ardanaz E, Martinez-Garcia C, Amiano P, Navarro C, Quiros JR, Key TJ, Reeves G, Khaw K-T, Bingham S, Trichopoulou A, Trichopoulos D, Naska A, Nagel G, Chang-Claude J, Boeing H, Lahmann PH, Manjer J, Wirfalt E, Hallmans G, Johansson I, Lund E, Skeie G, Hjartaker A, Ferrari P, Slimani N, Kaaks R, Riboli E (2007) Alcohol intake and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Cancer Causes Control 18(4):361–373PubMedCrossRef Tjonneland A, Christensen J, Olsen A, Stripp C, Thomsen BL, Overvad K, Peeters PHM, van Gils CH, Bueno-de-Mesquita HB, Ocke MC, Thiebaut A, Fournier A, Clavel-Chapelon F, Berrino F, Palli D, Tumino R, Panico S, Vineis P, Agudo A, Ardanaz E, Martinez-Garcia C, Amiano P, Navarro C, Quiros JR, Key TJ, Reeves G, Khaw K-T, Bingham S, Trichopoulou A, Trichopoulos D, Naska A, Nagel G, Chang-Claude J, Boeing H, Lahmann PH, Manjer J, Wirfalt E, Hallmans G, Johansson I, Lund E, Skeie G, Hjartaker A, Ferrari P, Slimani N, Kaaks R, Riboli E (2007) Alcohol intake and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Cancer Causes Control 18(4):361–373PubMedCrossRef
4.
Zurück zum Zitat Flom JD, Ferris JS, Tehranifar P, Terry MB (2009) Alcohol intake over the life course and mammographic density. Breast Cancer Res Treat 117(3):643–651PubMedCrossRef Flom JD, Ferris JS, Tehranifar P, Terry MB (2009) Alcohol intake over the life course and mammographic density. Breast Cancer Res Treat 117(3):643–651PubMedCrossRef
5.
Zurück zum Zitat Hellmann SS, Thygesen LC, Tolstrup JS, Gronbaek M (2010) Modifiable risk factors and survival in women diagnosed with primary breast cancer: results from a prospective cohort study. Eur J Cancer Prev 19(5):366–373PubMedCrossRef Hellmann SS, Thygesen LC, Tolstrup JS, Gronbaek M (2010) Modifiable risk factors and survival in women diagnosed with primary breast cancer: results from a prospective cohort study. Eur J Cancer Prev 19(5):366–373PubMedCrossRef
6.
Zurück zum Zitat Del Maso L, Zucchetto A, Talamini R, Serraino D, Stocco CF, Vercelli M, Falcini F, Franceschi S (2008) Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 123:2188–2194CrossRef Del Maso L, Zucchetto A, Talamini R, Serraino D, Stocco CF, Vercelli M, Falcini F, Franceschi S (2008) Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 123:2188–2194CrossRef
7.
Zurück zum Zitat Harris HR, Bergkvist L, Wolk A (2012) Alcohol intake and mortality among women with invasive breast cancer. Br J Cancer 106(3):592–595PubMedCrossRef Harris HR, Bergkvist L, Wolk A (2012) Alcohol intake and mortality among women with invasive breast cancer. Br J Cancer 106(3):592–595PubMedCrossRef
8.
Zurück zum Zitat Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Bersch AJ, Passarelli MN, Holick CN, Titus-Ernstoff L, Egan KM, Holmes MD, Willett WC (2011) Post-diagnosis dietary factors and survival after invasive breast cancer. Br Cancer Res Treat 128(1):229–236CrossRef Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Bersch AJ, Passarelli MN, Holick CN, Titus-Ernstoff L, Egan KM, Holmes MD, Willett WC (2011) Post-diagnosis dietary factors and survival after invasive breast cancer. Br Cancer Res Treat 128(1):229–236CrossRef
9.
Zurück zum Zitat Reding KW, Daling JR, Doody DR, O’Brien CA, Porter PL, Malone KE (2008) Effect of prediagnostic alcohol consumption on survival after breast cancer in young women. Cancer Epidemiol Biomarkers Prev 17(8):1988–1996PubMedCrossRef Reding KW, Daling JR, Doody DR, O’Brien CA, Porter PL, Malone KE (2008) Effect of prediagnostic alcohol consumption on survival after breast cancer in young women. Cancer Epidemiol Biomarkers Prev 17(8):1988–1996PubMedCrossRef
10.
Zurück zum Zitat Jain MG, Ferrence RG, Rehm JT, Bondy SJ, Rohan TE, Ashley MJ, Cohen JE, Miller AB (2000) Alcohol and breast cancer mortality in a cohort study. Breast Cancer Res Treat 64:201–209PubMedCrossRef Jain MG, Ferrence RG, Rehm JT, Bondy SJ, Rohan TE, Ashley MJ, Cohen JE, Miller AB (2000) Alcohol and breast cancer mortality in a cohort study. Breast Cancer Res Treat 64:201–209PubMedCrossRef
11.
Zurück zum Zitat Kwan ML, Kushi LH, Weltzien E, Tam EK, Castillo A, Sweeney C, Caan BJ (2010) Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clini Oncol 28(29):4410–4416CrossRef Kwan ML, Kushi LH, Weltzien E, Tam EK, Castillo A, Sweeney C, Caan BJ (2010) Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clini Oncol 28(29):4410–4416CrossRef
12.
Zurück zum Zitat Allemani C, Berrino F, Krogh V, Sieri S, Pupa SM, Tagliabue E, Tagliabue G, Sant M (2011) Do pre-diagnostic drinking habits influence breast cancer survival? Tumori 97(2):142–148PubMed Allemani C, Berrino F, Krogh V, Sieri S, Pupa SM, Tagliabue E, Tagliabue G, Sant M (2011) Do pre-diagnostic drinking habits influence breast cancer survival? Tumori 97(2):142–148PubMed
13.
Zurück zum Zitat Russo J, Hu YF, Silva ID, Russo IH (2001) Cancer risk related to mammary gland structure and development. Microsc Res Tech 52(2):204–223PubMedCrossRef Russo J, Hu YF, Silva ID, Russo IH (2001) Cancer risk related to mammary gland structure and development. Microsc Res Tech 52(2):204–223PubMedCrossRef
14.
Zurück zum Zitat Schedin PJ, Byers T (1997) Adolescent diet and the risk of breast cancer in adulthood: a role for vitamin A? Nutrition 13(10):924–925PubMedCrossRef Schedin PJ, Byers T (1997) Adolescent diet and the risk of breast cancer in adulthood: a role for vitamin A? Nutrition 13(10):924–925PubMedCrossRef
15.
Zurück zum Zitat Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU (2006) Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 17(10):1253–1261PubMedCrossRef Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU (2006) Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 17(10):1253–1261PubMedCrossRef
16.
Zurück zum Zitat Dorn JM, Hovey K, Williams BA, Freudenheim JL, Russell M, Nochajski TH, Trevisan M (2007) Alcohol drinking pattern and non-fatal myocardial infarction in women. Addiction 102(5):730–739PubMedCrossRef Dorn JM, Hovey K, Williams BA, Freudenheim JL, Russell M, Nochajski TH, Trevisan M (2007) Alcohol drinking pattern and non-fatal myocardial infarction in women. Addiction 102(5):730–739PubMedCrossRef
17.
Zurück zum Zitat Fan AZ, Russell M, Dorn J, Freudenheim JL, Nochajski T, Hovey K, Trevisan M (2006) Lifetime alcohol drinking pattern is related to the prevalence of metabolic syndrome. The Western New York Health Study (WNYHS). Eur J Epidemiol 21(2):129–138PubMedCrossRef Fan AZ, Russell M, Dorn J, Freudenheim JL, Nochajski T, Hovey K, Trevisan M (2006) Lifetime alcohol drinking pattern is related to the prevalence of metabolic syndrome. The Western New York Health Study (WNYHS). Eur J Epidemiol 21(2):129–138PubMedCrossRef
18.
Zurück zum Zitat Trevisan M, Dorn J, Falkner K, Russell M, Ram M, Muti P, Freudenheim JL, Nochajaski T, Hovey K (2003) Drinking pattern and risk of non-fatal myocardial infarction: a population-based case-control study. Addiction 99(3):313–322CrossRef Trevisan M, Dorn J, Falkner K, Russell M, Ram M, Muti P, Freudenheim JL, Nochajaski T, Hovey K (2003) Drinking pattern and risk of non-fatal myocardial infarction: a population-based case-control study. Addiction 99(3):313–322CrossRef
19.
Zurück zum Zitat Platek ME, Shields PG, Marian C, McCann SE, Bonner MR, Nie J, Ambrosone CB, Millen AE, Ochs-Balcom HM, Quick SK, Trevisan M, Russell M, Nochajski TH, Edge SB, Freudenheim JL (2009) Alcohol consumption and genetic variation in Methylenetetrahydrofolate Reductase and 5-Methyltetrahydrofolate-Homocysteine Methyltransferase in relation to breast cancer risk. Cancer Epidemiol Biomark Prev 18:2453–2459CrossRef Platek ME, Shields PG, Marian C, McCann SE, Bonner MR, Nie J, Ambrosone CB, Millen AE, Ochs-Balcom HM, Quick SK, Trevisan M, Russell M, Nochajski TH, Edge SB, Freudenheim JL (2009) Alcohol consumption and genetic variation in Methylenetetrahydrofolate Reductase and 5-Methyltetrahydrofolate-Homocysteine Methyltransferase in relation to breast cancer risk. Cancer Epidemiol Biomark Prev 18:2453–2459CrossRef
20.
Zurück zum Zitat McCann SE, Thompson LU, Nie J, Dorn J, Trevisan M, Shields PG, Ambrosone CB, Edge SB, Li H-F, Kasprzak C, Freudenheim JL (2009) Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York exposures and breast cancer (WEB) Study. Breast Cancer Res Treat 122:229–235PubMedCrossRef McCann SE, Thompson LU, Nie J, Dorn J, Trevisan M, Shields PG, Ambrosone CB, Edge SB, Li H-F, Kasprzak C, Freudenheim JL (2009) Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York exposures and breast cancer (WEB) Study. Breast Cancer Res Treat 122:229–235PubMedCrossRef
21.
Zurück zum Zitat Bonner MR, Nie J, Han D, Vena JE, Rogerson P, Muti P, Trevisan M, Edge SB, Freudenheim JL (2005) Secondhand smoke exposure in early life and the risk of breast cancer among never smokers (United States). Cancer Causes Control 16(6):683–689PubMedCrossRef Bonner MR, Nie J, Han D, Vena JE, Rogerson P, Muti P, Trevisan M, Edge SB, Freudenheim JL (2005) Secondhand smoke exposure in early life and the risk of breast cancer among never smokers (United States). Cancer Causes Control 16(6):683–689PubMedCrossRef
22.
Zurück zum Zitat Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124(3):453–469PubMed Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124(3):453–469PubMed
23.
Zurück zum Zitat Russell M, Marshall JR, Trevisan M, Freudenheim JL, Chan AW, Markovic N, Vana JE, Priore RL (1997) Test-retest reliability of the cognitive lifetime drinking history. Am J Epidemiol 146(11):975–981PubMedCrossRef Russell M, Marshall JR, Trevisan M, Freudenheim JL, Chan AW, Markovic N, Vana JE, Priore RL (1997) Test-retest reliability of the cognitive lifetime drinking history. Am J Epidemiol 146(11):975–981PubMedCrossRef
24.
Zurück zum Zitat Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathol 11(2):155–168 Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathol 11(2):155–168
25.
Zurück zum Zitat Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Goerlitz DS, Trevisan M, Shields PG, Freudenheim JL (2011) Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control 22(7):965–975PubMedCrossRef Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Goerlitz DS, Trevisan M, Shields PG, Freudenheim JL (2011) Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control 22(7):965–975PubMedCrossRef
26.
Zurück zum Zitat Longnecker MP, Paganini-Hill A, Ross RK (1995) Lifetime alcohol consumption and breast cancer risk among postmenopausal women in Los Angeles. Cancer Epidemiol Biomark Prev 4(7):721–725 Longnecker MP, Paganini-Hill A, Ross RK (1995) Lifetime alcohol consumption and breast cancer risk among postmenopausal women in Los Angeles. Cancer Epidemiol Biomark Prev 4(7):721–725
27.
Zurück zum Zitat Terry MB, Zhang FF, Kabat G, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD (2006) Lifetime alcohol intake and breast cancer risk. Ann Epidemiol 16(3):230–240PubMedCrossRef Terry MB, Zhang FF, Kabat G, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD (2006) Lifetime alcohol intake and breast cancer risk. Ann Epidemiol 16(3):230–240PubMedCrossRef
28.
Zurück zum Zitat Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW Jr, Doll R (1997) Alcohol consumption and mortality among middle-aged and elderly U S adults. N Engl J Med 337(24):1705–1714PubMedCrossRef Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW Jr, Doll R (1997) Alcohol consumption and mortality among middle-aged and elderly U S adults. N Engl J Med 337(24):1705–1714PubMedCrossRef
29.
Zurück zum Zitat Holm M, Olsen A, Christensen J, Kroman NT, Bidstrup PE, Johansen C, Overvad K, Tjonneland A (2012) Pre-diagnostic alcohol consumption and breast cancer recurrence and mortality: results from a prospective cohort with a wide range of variation in alcohol intake. Int J Cancer 132(3):686–694PubMedCrossRef Holm M, Olsen A, Christensen J, Kroman NT, Bidstrup PE, Johansen C, Overvad K, Tjonneland A (2012) Pre-diagnostic alcohol consumption and breast cancer recurrence and mortality: results from a prospective cohort with a wide range of variation in alcohol intake. Int J Cancer 132(3):686–694PubMedCrossRef
Metadaten
Titel
Alcohol intake over the life course and breast cancer survival in Western New York exposures and breast cancer (WEB) study: quantity and intensity of intake
verfasst von
Anne M. Weaver
Susan E. McCann
Jing Nie
Stephen B. Edge
Thomas H. Nochajski
Marcia Russell
Maurizio Trevisan
Jo L. Freudenheim
Publikationsdatum
01.05.2013
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2013
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2533-y

Weitere Artikel der Ausgabe 1/2013

Breast Cancer Research and Treatment 1/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.